Manufacturing & Packaging

CDMO’s North Carolina production site will be engineering Covid-19 vaccine doses

Production of the key component of gene therapies and certain vaccines for Covid-19 hampered by insufficient manufacturing capacity, according to GlobalData

Vaccine maker will use CDMO’s South Korean facilities to support additional Covid doses

Expansion features a new lyophilization center to meet point-of-care demand

Facility will house 44,000 square feet of clinical and commercial cGMP, and other tech services

Expansion establishes role it plays in the oncology sector, company suggests

Pauses per manufacturer due to label-printing problems occur just under six times a year, on average, report finds

New sterile production area at Italy facility aims to benefit biologics manufacturing, such as BSL vaccines

Company also plans to design a manufacturing site for future mRNA vaccines and therapeutics

Will use new facility in Belgium for commercial production of plasmid DNA

CDMO giant invests nearly $1 billion in Switzerland and New Hampshire sites

Renovation more than doubles size of Massachusetts facility

Company also says that drug substance manufacturing can double at its facilities

As India Covid cases continue to spike, biotech company will provide resources to help boost local manufacturing

Partnership will begin with tackling Friedreich’s ataxia, then extend to other gene transfer therapies

Intends to provide fill-and-finish services for up to 200 million doses

Leiden site will be the company's fifth such facility, and first in Europe

FDA launches investigation into last month’s dose contamination

Sanford, NC, facility will be its sixth globally

Madison, WI, site now contains five manufacturing suites

Upon completion of five-year project, the location will serve as Asian hub for dose manufacturing

Dedicate new high-speed vial filling line for production of Moderna's Covid-19 vaccine

Agreement will now include fill-finish services at San Diego facility

With construction of third production line finished, biotech company says it can manufacture two billion doses annually

Acquisition further develops KD Pharma’s CDMO capabilities

The big pharma will help fill and finish up to 60 million doses of Novavax' coronavirus candidate

Expansion in response to growing industry demand for products to transport temperature-sensitive cell and gene therapies

Location will be purchased by WuXi Biologics, according to report

Puts packaging business on pace for 2 billion by end of year

The 130,000-square-foot site will be the CDMO's third location